SOPHiA GENETICS SA
SOPH
87 insider filings · Latest: Jun 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Apr 21 8:04 PM | Jurgi CamblongDirector, Chief Executive Officer | Sale | 4,486 | $5.21 | $23.3K | 3,642,481(D) | View → |
| Apr 20, 2026 | Apr 21 8:04 PM | Philippe MenuChief Medical Officer | Sale | 608 | $5.20 | $3.2K | 266,388(D) | View → |
| Apr 20, 2026 | Apr 21 8:04 PM | Ross MukenPresident | Sale | 760 | $5.20 | $4.0K | 681,672(D) | View → |
| Apr 20, 2026 | Apr 21 8:04 PM | Kevin PuylaertChief Sales Officer | Sale | 33 | $5.08 | $168 | 148,197(D) | View → |
| Apr 20, 2026 | Apr 20 8:32 PM | PHILIPPE MENU | Proposed Sale | 10,608 | $5.28 | $56.0K | — | View → |
| Apr 20, 2026 | Apr 20 8:32 PM | JURGI CAMBLONG | Proposed Sale | 12,986 | $5.28 | $68.6K | — | View → |
| Apr 20, 2026 | Apr 20 8:32 PM | MANUELA VALENTE | Proposed Sale | 380 | $5.28 | $2.0K | — | View → |
| Apr 20, 2026 | Apr 20 8:32 PM | ZHENYU XU | Proposed Sale | 4,608 | $5.28 | $24.3K | — | View → |
| Apr 20, 2026 | Apr 20 8:32 PM | ROSS J MUKEN | Proposed Sale | 760 | $5.28 | $4.0K | — | View → |
| Apr 20, 2026 | Apr 20 8:29 PM | DAAN GUIDO MARIA VAN WELL | Proposed Sale | 684 | $5.28 | $3.6K | — | View → |
| Apr 14, 2026 | Apr 16 8:03 PM | Zhenyu XuChief Scientific Officer | Sale | 600 | $4.97 | $3.0K | 631,496(D) | View → |
| Apr 15, 2026 | Apr 16 8:03 PM | Jurgi CamblongDirector, Chief Executive Officer | Sale | 17,473 | $5.00 | $87.4K | 3,646,967(D) | View → |
| Apr 14, 2026 | Apr 16 8:03 PM | Jurgi CamblongDirector, Chief Executive Officer | Sale | 43,129 | $4.96 | $213.8K | 3,664,440(D) | View → |
| Apr 14, 2026 | Apr 16 8:03 PM | Philippe MenuChief Medical Officer | Sale | 1,600 | $4.96 | $7.9K | 266,996(D) | View → |
| Apr 14, 2026 | Apr 16 8:03 PM | Ross MukenPresident | Sale | 2,800 | $4.96 | $13.9K | 682,432(D) | View → |
| Apr 10, 2026 | Apr 14 8:02 PM | Well Daan VanChief Legal Officer | Sale | 2,400 | $4.67 | $11.2K | 346,420(D) | View → |
| Apr 13, 2026 | Apr 14 8:02 PM | Zhenyu XuChief Scientific Officer | Sale | 4,414 | $4.76 | $21.0K | 632,096(D) | View → |
| Apr 10, 2026 | Apr 14 8:02 PM | Zhenyu XuChief Scientific Officer | Sale | 3,706 | $4.68 | $17.3K | 636,510(D) | View → |
| Apr 13, 2026 | Apr 14 8:02 PM | Jurgi CamblongDirector, Chief Executive Officer | Sale | 4,399 | $4.76 | $21.0K | 3,707,569(D) | View → |
| Apr 10, 2026 | Apr 14 8:02 PM | Jurgi CamblongDirector, Chief Executive Officer | Sale | 12,232 | $4.72 | $57.7K | 3,711,968(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Apr 3 10:59 AM | Zhenyu XuChief Scientific Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Jurgi CamblongDirector, Chief Executive Officer | Grant/Award | 628,743 | $5.04 | 628,743(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Kevin PuylaertChief Sales Officer | Grant/Award | 82,335 | $5.04 | 82,335(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | George CardozaChief Financial Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:58 AM | Manuela ValenteChief People Officer | Grant/Award | 104,790 | $5.04 | 104,790(D) | View → |
| Apr 2, 2026 | Apr 3 10:58 AM | Well Daan VanChief Legal Officer | Grant/Award | 142,216 | $5.04 | 142,216(D) | View → |
← Previous
Page 2 of 2